{"prompt": "['Product: MK-3475', '126', 'Protocol/Amendment No.: 604-09', '[30]', 'Hillen F, Baeten CIM, van de Winkel A, Creytens D, van der Schaft DWJ,', 'Winnepenninckx V, et al. Leukocyte infiltration and tumor cell plasticity are', 'parameters of aggressiveness in primary cutaneous melanoma. Cancer Immunol', 'Immunother 2008;57(1):97-106.', '[31]', 'Laghi L, Bianchi P, Miranda E, Balladore E, Pacetti V, Grizzi F, et al. CD3+ cells', 'at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of', 'post-surgical metastatsis: a longitudinal study. Lancet Oncol 2009; 10:877-84.', '[32]', 'Li JF, Chu YW, Wang GM, Zhu TY, Rong RM, Hou J, et al. The prognostic value', 'of peritumoral regulatory T cells and its correlation with intratumoral', 'cyclooxygenase-2 expression in clear cell renal cell carcinoma. BJU Intern', '2008;103:399-405.', '[33]', 'Nemolato S, Fanni D, Naccarato AG, Ravarino A, Bevilacqua G, Faa G.', 'Lymphoepithelioma-like hepatocellular carcinoma: a case report and a review of', 'the literature. World J Gastroenterol 2008;14(29):4694-6.', '[34]', 'Nobili C, Degrate L, Caprotti R, Franciosi C, Leone BE, Trezzi R, et al. Prolonged', 'survival of a patient affected by pancreatic adenocarcinoma with massive', 'lymphocyte and dendritic cell infiltration after interleukin-2 immunotherapy.', 'Report of a case. Tumori 2008;94(3):426-30.', '[35]', 'Oshikiri T, Miyamoto M, Shichinohe T, Suzuoki M, Hiraoka K, Nakakubo Y, et', 'al. Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct', 'carcinoma as essential immune response. J Surg Oncol 2003;84:224-8.', '[36]', 'Piersma SJ, Welters MJP, van der Burg SH. Tumor-specific regulatory T cells in', 'cancer patients. Human Immunol 2008;69:241-9.', '[37]', 'Rao UNM, Lee SJ, Luo W, Mihm Jr. MC, Kirkwood JM. Presence of tumor-', 'infiltrating lymphocytes and a dominant nodule within primary melanoma are', 'prognostic factors for relapse-free survival of patients with thick (T4) primary', 'melanoma: pathologic analysis of the E1690 and E1694 intergroup trials. Am J', 'Clin Pathol 2010;133:646-53.', '[38]', 'Sasaki A, Tanaka F, Mimori K, Inoue H, Kai S, Shibata K, et al. Prognostic value', 'of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular', 'carcinoma. EJSO 2008;34:173-9.', '[39]', 'Shen Z, Zhou S, Wang Y, Li R, Zhong C, Liang C, et al. Higher intratumoral', 'infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with', 'adverse prognosis in resectable gastric cancer. J Cancer Res Clin Oncol', '2010;136:1585-95.', 'MK-3475-604-09 Final Protocol', '23-Apr-2019', 'Confidential']['Product: MK-3475', '127', 'Protocol/Amendment No.: 604-09', '[40]', 'Talmadge JE, Donkor M, Scholar E. Inflammatory cell infiltration of tumors:', 'Jekyll or Hyde. Cancer Metastasis Rev 2007;26(3-4):373-400.', '[41]', 'Usub\u00fct\u00fcn A, Ayhan A, Uygur MC, \u00d6zen H, Toklu C, Ruacan S. Prognostic', 'factors in renal cell carcinoma. J Exp Clin Cancer Res 1998;17(1):77-81.', '[42]', 'Leffers N, Gooden MJM, de Jong RA, Hoogeboom B-N, ten Hoor KA, Hollema', 'H, et al. Prognostic significance of tumor-infiltrating T-lymphocytes in primary', 'and metastatic lesions of advanced stage ovarian cancer. Cancer Immunol', 'Immunother 2009;58(3):449-59.', '[43]', 'Nishimura H, Honjo T, Minato N. Facilitation of beta selection and modification', 'of positive selection in the thymus of PD-1-deficient mice. J Exp Med. 2000 Mar', '6;191(5):891-8.', '[44]', 'P\u00f6lcher M, Braun M, Friedrichs N, Rudlowski C, Bercht E, Fimmers R, et al.', 'Foxp3(+) cell infiltration and granzyme B(+)/Foxp3(+) cell ratio are associated', 'with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma. Cancer', 'Immunol Immunother 2010;59(6):909-19.', '[45]', 'Suzuki H, Chikazawa N, Tasaka T, Wada J, Yamasaki A, Kitaura Y, et al.', 'Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in', 'patients with colorectal cancer. Cancer Immunol Immunother 2010;59:653-61.', '[46]', 'Chew V, Tow C, Teo M, Wong HL, Chan J, Gehring A, et al. Inflammatory tumor', 'microenvironment is associated with superior survival in hepatocellular carcinoma', 'patients. J Hepatol 2010;52:370-9.', '[47]', 'Liotta F, Gacci M, Frosali F, Querci V, Vittori G, Lapini A, et al. Frequency of', 'regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes', 'correlates with poor prognosis in renal cell carcinoma. BJU Int 2011;107(9):1500-', '6.', '[48]', 'Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma V-M. Prognostic', 'value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol', '1997;182(3):318-24.', '[49]', 'Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, et al.', 'Adoptive cell transfer therapy following non-myeloablative but lymphodepleting', 'chemotherapy for the treatment of patients with refractory metastatic melanoma. J', 'Clin Oncol 2005;23(10):2346-57.', '[50]', 'Hunder NN, Wallen H, Cao J, Hendricks DW, Reilly JZ, Rodmyre R, et al.', 'Treatment of metastatic melanoma with autologous CD4+ T cells against NY-', 'ESO-1. N Engl J Med 2008;358(25):2698-703', 'MK-3475-604-09 Final Protocol', '23-Apr-2019', 'Confidential']\n\n###\n\n", "completion": "END"}